Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5774584

CN(C(=O)CCc1cnoc1-c1ccc(F)cc1)C1CCN(Cc2ccccc2)C1.O=C(O)C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
KCNH2 Q12809 1/20 0.44
OPRM1 P35372 3/20 0.41
CCR5 P51681 2/20 0.41
DRD2 P14416 1/20 0.40
DRD4 P21917 1/20 0.40
CHRM4 P08173 3/20 0.40
CHRM2 P08172 1/20 0.39
CHRM3 P20309 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC9 Q9UKV0 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38
NCOR2 Q9Y618 1/20 0.38
TMEM97 Q5BJF2 1/20 0.38
PRCP P42785 1/20 0.38
ACHE P22303 1/20 0.38
MCHR1 Q99705 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5773674 0.90 OPRM1 (0.47) OPRM1DRD2DRD4CHRM2CHRM3
SCHEMBL5774218 0.85 OPRM1 (0.50) MEN1KMT2AOPRM1DRD2DRD4
Trifluoroacetic Acid SCHEMBL5776131 0.85 LMNA (0.42) MEN1KMT2AKCNH2CCR5MCHR1
SCHEMBL5771833 0.83 DRD2 (0.42) OPRM1DRD2DRD4CHRM4HDAC3
Trifluoroacetic Acid SCHEMBL5771830 0.83 DRD2 (0.54) DRD2DRD4HDAC3HDAC4HDAC7
Trifluoroacetic Acid SCHEMBL5776822 0.79 DPP8 (0.50) MEN1KMT2A
Trifluoroacetic Acid SCHEMBL5773114 0.78 LMNA (0.41) KMT2AKCNH2CCR5HDAC4MCHR1
Trifluoroacetic Acid SCHEMBL5774450 0.78 HTT (0.40) CHRM4PRCPMCHR1
SCHEMBL5773476 0.78 DRD2 (0.46) KCNH2OPRM1DRD2DRD4CHRM4
Trifluoroacetic Acid SCHEMBL5773475 0.77 DRD4 (0.58) DRD2DRD4HDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR MEN1 2811/4885KMT2A 3907/4885KCNH2 1149/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 MEN1 2072/4885KMT2A 2906/4885KCNH2 834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.